| |
|
|
| Name: |
Logos Global Management LP |
| City: |
San Francisco |
| State: |
CA |
| Zip: |
94104 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
19 |
|
View All Holdings |
Currently
Viewing:
New Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
CLDX |
Celldex Therapeutics Inc |
13 |
New |
$34.22 |
$27,281,000 |
650,000 |
2.87% |
27,281,000 |
650,000 |
1.033 |
Diagnostic Substances |
|
|
VERA |
Vera Therapeutics, Inc. |
15 |
New |
$0.00 |
$24,794,000 |
575,000 |
2.61% |
24,794,000 |
575,000 |
1.358 |
N/A |
|
|
ADVM |
Adverum Biotechnologies, Inc |
17 |
New |
$8.02 |
$21,210,000 |
1,499,999 |
2.23% |
21,210,000 |
1,499,999 |
1.485 |
N/A |
|
|
CYBN |
Cybin Inc |
21 |
New |
$0.35 |
$16,540,000 |
40,000,000 |
1.74% |
16,540,000 |
40,000,000 |
25.222 |
N/A |
|
|
XNCR |
Xencor Inc |
22 |
New |
$23.19 |
$14,385,000 |
650,000 |
1.51% |
14,385,000 |
650,000 |
0.979 |
Biotechnology |
|
|
CGON |
CG Oncology, Inc |
23 |
New |
$32.40 |
$13,170,000 |
300,000 |
1.39% |
13,170,000 |
300,000 |
0.455 |
N/A |
|
|
ENGN |
Engene Holdings Inc. |
24 |
New |
$12.74 |
$12,882,000 |
800,000 |
1.36% |
12,882,000 |
800,000 |
3.448 |
N/A |
|
|
KYTX |
Kyverna Therapeutics |
25 |
New |
$12.83 |
$12,420,000 |
500,000 |
1.31% |
12,420,000 |
500,000 |
1.163 |
N/A |
|
|
CGEM |
Cullinan Oncology Ord Shs |
27 |
New |
$0.00 |
$11,928,000 |
700,000 |
1.26% |
11,928,000 |
700,000 |
1.608 |
N/A |
|
|
LCTX |
Lineage Cell Therapeutics O... |
30 |
New |
$0.92 |
$9,250,000 |
6,250,000 |
0.97% |
9,250,000 |
6,250,000 |
4.167 |
Biotechnology |
|
|
PRAX |
Praxis Precision Medicines,... |
31 |
New |
$0.00 |
$9,153,000 |
150,000 |
0.96% |
9,153,000 |
150,000 |
0.286 |
N/A |
|
|
SNDX |
Syndax Pharmaceuticals Inc |
33 |
New |
$19.72 |
$8,330,000 |
350,000 |
0.88% |
8,330,000 |
350,000 |
0.372 |
N/A |
|
|
TRVI |
Trevi Therapeutics, Inc. |
34 |
New |
$0.00 |
$7,590,000 |
2,200,000 |
0.8% |
7,590,000 |
2,200,000 |
3.672 |
N/A |
|
|
KURA |
Kura Oncology Inc |
36 |
New |
$20.47 |
$6,399,000 |
300,000 |
0.67% |
6,399,000 |
300,000 |
0.358 |
N/A |
|
|
JANX |
Janux Therapeutics, Inc. |
39 |
New |
$0.00 |
$5,648,000 |
150,000 |
0.59% |
5,648,000 |
150,000 |
0.376 |
N/A |
|
|
ELEV |
Elevation Oncology, Inc. |
40 |
New |
$3.97 |
$5,130,000 |
1,000,000 |
0.54% |
5,130,000 |
1,000,000 |
2.358 |
N/A |
|
|
NXTC |
Nextcure, Inc. |
41 |
New |
$0.00 |
$4,293,000 |
1,925,000 |
0.45% |
4,293,000 |
1,925,000 |
6.987 |
N/A |
|
|
UNCY |
Unicycive Therapeutics, Inc. |
43 |
New |
$0.00 |
$3,011,000 |
3,469,927 |
0.32% |
3,011,000 |
3,469,927 |
23.914 |
N/A |
|
|
BOLD |
Boundless Bio, Inc. |
44 |
New |
$8.72 |
$2,850,000 |
200,000 |
0.3% |
2,850,000 |
200,000 |
0.899 |
N/A |
|
